The identification and validation of Auger electron-emitting radiopharmaceuticals targeting telomerase for cancer therapy
<p>Telomerase is expressed in the majority (>85%) of tumours but not in differentiated normal tissue. This enzyme catalyses the elongation of telomeres – a process critical for continued cell proliferation. Telomerase is a potential novel target for molecularly-targeted radiotherapy (mR...
Yazar: | |
---|---|
Diğer Yazarlar: | |
Materyal Türü: | Tez |
Dil: | English |
Baskı/Yayın Bilgisi: |
2013
|
Konular: |